These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23271772)

  • 1. Presenting treatment options to men with clinically localized prostate cancer: the acceptability of active surveillance/monitoring.
    Donovan JL
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):191-6. PubMed ID: 23271772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.
    Hoffman RM
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):197-201. PubMed ID: 23271773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evidence review of active surveillance in men with localized prostate cancer.
    Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
    Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.
    Hayes JH; Ollendorf DA; Pearson SD; Barry MJ; Kantoff PW; Stewart ST; Bhatnagar V; Sweeney CJ; Stahl JE; McMahon PM
    JAMA; 2010 Dec; 304(21):2373-80. PubMed ID: 21119084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
    Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
    Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
    O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
    Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
    Wilt TJ
    Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for localized prostate cancer.
    Mohan R; Schellhammer PF
    Am Fam Physician; 2011 Aug; 84(4):413-20. PubMed ID: 21842788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decision analysis comparing 3 active surveillance protocols for the treatment of patients with low-risk prostate cancer.
    White C; Nimeh T; Gazelle GS; Weinstein MC; Loughlin KR
    Cancer; 2019 Mar; 125(6):952-962. PubMed ID: 30561761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.
    Fitch M; Pang K; Ouellet V; Loiselle C; Alibhai S; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; Sutcliffe S; So A; Tanguay S; Saad F; Mes-Masson AM
    BMC Urol; 2017 Oct; 17(1):98. PubMed ID: 29078772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
    Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
    Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Narrative Overview of Active Surveillance for Clinically Localised Prostate Cancer.
    Bates AS; Kostakopoulos N; Ayers J; Jameson M; Todd J; Lukha R; Cymes W; Chasapi D; Brown N; Bhattacharya Y; Paterson C; Lam TBL
    Semin Oncol Nurs; 2020 Aug; 36(4):151045. PubMed ID: 32703714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.
    Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL
    Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
    Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
    J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized Prostate Cancer: Treatment Options.
    Brawley S; Mohan R; Nein CD
    Am Fam Physician; 2018 Jun; 97(12):798-805. PubMed ID: 30216009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of clinically localized prostate cancer patients managed with initial monitoring approach versus upfront local treatment: a North American population-based study.
    Abdel-Rahman O
    Clin Transl Oncol; 2019 Dec; 21(12):1673-1679. PubMed ID: 30929179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active surveillance for prostate cancer: past, present and future.
    Singer EA; Kaushal A; Turkbey B; Couvillon A; Pinto PA; Parnes HL
    Curr Opin Oncol; 2012 May; 24(3):243-50. PubMed ID: 22450149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.